Adults are more likely to have learned about GLP-1s by chance than actively seek out information
a figure that many patients on GLP-1 therapy fall short of, partly because the appetite suppression the medications produce makes hitting protein targets without conscious effort difficult. Clinical note Patients on GLP-1 therapy frequently report that protein-rich foods (particularly meat and eggs) become less palatable during treatment
(This article uses 'men' to reflect the language used in the review and other studies, while recognizing that not all people who have sperm identify themselves as men.) In one study, for example, 30 men with low testosterone levels, a condition known as hypogonadism, and obesity were assigned to receive either a GLP-1 drug or testosterone replacement therapy (TRT) at random
The weight-loss figures in circulation come from the approved brand programmes, such as Wegovy Study 2, which reported mean body weight change of minus 14.9% versus minus 2.4% with placebo over 68 weeks
Veterinria e Zootecnia 19(4), 470479
Molecules 2018;23:106.
